Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Interest expense on outstanding debt
3Y CAGR
+3.9%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $73000.00 | -48.6% |
| 2024 | $142000.00 | -24.1% |
| 2023 | $187000.00 | +187.7% |
| 2022 | $65000.00 | +2066.7% |
| 2021 | $3000.00 | - |